| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 155, Issue 3 1165-1174, Copyright © 1995 by American Association of Immunologists
ARTICLES |
W Steurer, PW Nickerson, AW Steele, J Steiger, XX Zheng and TB Strom
Harvard Medical School, Department of Medicine, Boston, MA, USA.
To test the hypothesis that blockade of B7-triggered costimulation by donor cells could preclude allograft rejection, we coated crude islet allograft preparations in vitro for 1 h with a murine CTLA4/Fc fusion protein. Murine CTLA4/Fc blocks the proliferative response in primary mixed lymphocyte cultures (MLC) and Con A-stimulated murine spleen cell cultures by 85 to 95%. Responder cells from a primary MLC containing mCTLA4/Fc were hyporesponsive upon restimulation to the same stimulator cells in a secondary MLC lacking mCTLA4/Fc. Because of mutations in the Fc gamma RI and C'1q binding sites of the Fc portion of the murine CTLA4/Fc fusion protein, the molecule binds to, but does not target, cells for Ab-dependent cellular cytotoxicity or complement-directed cytolysis. Although systemic immunosuppression was not applied, 42% (10 of 24) of B6AF1 recipients of islet allografts pretreated with CTLA4/Fc were permanently engrafted. Further, 50% of hosts bearing functioning islet allografts more than 150 days post-transplant were formally proved to be tolerant to donor tissues. A persistent CD4+ and CD8+ T cell infiltrate surrounding, but not invading, islet grafts in tolerant hosts was discerned. In control experiments, 89% (8 of 9) of islet allografts coated with mIgG3, and 100% (n = 10) pretreated with media alone were rejected. Thus, we conclude that 1) B7-triggered costimulation by donor APCs is an important element of rejection, and 2) blockade of the B7 pathway by in vitro allograft manipulation is able to induce tolerance.
This article has been cited by other articles:
|
|
 |
|
  D. Herber, T. P. Brown, S. Liang, D. A. Young, M. Collins, and K. Dunussi-Joannopoulos IL-21 Has a Pathogenic Role in a Lupus-Prone Mouse Model and Its Blockade with IL-21R.Fc Reduces Disease Progression J. Immunol., March 15, 2007; 178(6): 3822 - 3830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Domenig, A. Sanchez-Fueyo, J. Kurtz, S. P. Alexopoulos, C. Mariat, M. Sykes, T. B. Strom, and X. X. Zheng Roles of Deletion and Regulation in Creating Mixed Chimerism and Allograft Tolerance Using a Nonlymphoablative Irradiation-Free Protocol J. Immunol., July 1, 2005; 175(1): 51 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Esparza and R. H. Arch Glucocorticoid-Induced TNF Receptor Functions as a Costimulatory Receptor That Promotes Survival in Early Phases of T Cell Activation J. Immunol., June 15, 2005; 174(12): 7869 - 7874. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Machen, J. Harnaha, R. Lakomy, A. Styche, M. Trucco, and N. Giannoukakis Antisense Oligonucleotides Down-Regulating Costimulation Confer Diabetes-Preventive Properties to Nonobese Diabetic Mouse Dendritic Cells J. Immunol., October 1, 2004; 173(7): 4331 - 4341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Demirci, T. B. Strom, and X. C. Li Islet Allograft Rejection in Nonobese Diabetic Mice Involves the Common {gamma}-Chain and CD28/CD154-Dependent and -Independent Mechanisms J. Immunol., October 1, 2003; 171(7): 3878 - 3885. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Demirci, W. Gao, X. X. Zheng, T. R. Malek, T. B. Strom, and X. C. Li On CD28/CD40 Ligand Costimulation, Common {gamma}-Chain Signals, and the Alloimmune Response J. Immunol., May 1, 2002; 168(9): 4382 - 4390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Comer, W. J. King, N. Ardjomand, S. Theoharis, A. J. T. George, and D. F. P. Larkin Effect of Administration of CTLA4-Ig as Protein or cDNA on Corneal Allograft Survival Invest. Ophthalmol. Vis. Sci., April 1, 2002; 43(4): 1095 - 1103. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ferrari-Lacraz, X. X. Zheng, Y. S. Kim, Y. Li, W. Maslinski, X. C. Li, and T. B. Strom An Antagonist IL-15/Fc Protein Prevents Costimulation Blockade-Resistant Rejection J. Immunol., September 15, 2001; 167(6): 3478 - 3485. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ito, J. Kurtz, J. Shaffer, and M. Sykes CD4 T Cell-Mediated Alloresistance to Fully MHC-Mismatched Allogeneic Bone Marrow Engraftment Is Dependent on CD40-CD40 Ligand Interactions, and Lasting T Cell Tolerance Is Induced by Bone Marrow Transplantation with Initial Blockade of this Pathway J. Immunol., March 1, 2001; 166(5): 2970 - 2981. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Quesenberry, S. Zhong, H. Wang, and M. Stewart Allogeneic chimerism with low-dose irradiation, antigen presensitization, and costimulator blockade in H-2 mismatched mice Blood, January 15, 2001; 97(2): 557 - 564. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Todo, R. L. Martuza, M. J. Dallman, and S. D. Rabkin In Situ Expression of Soluble B7-1 in the Context of Oncolytic Herpes Simplex Virus Induces Potent Antitumor Immunity Cancer Res., January 1, 2001; 61(1): 153 - 161. [Abstract] [Full Text]
|
|
|
|
|
|
C. Guillot, P. Mathieu, H. Coathalem, B. Le Mauff, M. G. Castro, L. Tesson, C. Usal, T. Laumonier, S. Brouard, J.-P. Soulillou, et al. Tolerance to Cardiac Allografts Via Local and Systemic Mechanisms After Adenovirus-Mediated CTLA4Ig Expression J. Immunol., May 15, 2000; 164(10): 5258 - 5268. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Ling, P. W. Wu, H. F. Finnerty, K. M. Bean, V. Spaulding, L. A. Fouser, J. P. Leonard, S. E. Hunter, R. Zollner, J. L. Thomas, et al. Cutting Edge: Identification of GL50, a Novel B7-Like Protein That Functionally Binds to ICOS Receptor J. Immunol., February 15, 2000; 164(4): 1653 - 1657. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Qian, M. Collins, A. H. Sharpe, and L. W. Hoyer Prevention and treatment of factor VIII inhibitors in murine hemophilia A Blood, February 15, 2000; 95(4): 1324 - 1329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sturmhoefel, K. Lee, G. S. Gray, J. Thomas, R. Zollner, M. O'Toole, H. Swiniarski, A. Dorner, and S. F. Wolf Potent Activity of Soluble B7-IgG Fusion Proteins in Therapy of Established Tumors and as Vaccine Adjuvant Cancer Res., October 1, 1999; 59(19): 4964 - 4972. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Gorczynski, M. S. Cattral, Z. Chen, J. Hu, J. Lei, W.-P. Min, G. Yu, and J. Ni An Immunoadhesin Incorporating the Molecule OX-2 Is a Potent Immunosuppressant That Prolongs Allo- and Xenograft Survival J. Immunol., August 1, 1999; 163(3): 1654 - 1660. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. X. Zheng, T. G. Markees, W. W. Hancock, Y. Li, D. L. Greiner, X. C. Li, J. P. Mordes, M. H. Sayegh, A. A. Rossini, and T. B. Strom CTLA4 Signals Are Required to Optimally Induce Allograft Tolerance with Combined Donor-Specific Transfusion and Anti-CD154 Monoclonal Antibody Treatment J. Immunol., April 15, 1999; 162(8): 4983 - 4990. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. ROSSINI, D. L. GREINER, and J. P. MORDES Induction of Immunologic Tolerance for Transplantation Physiol Rev, January 1, 1999; 79(1): 99 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Sayegh and L. A. Turka The Role of T-Cell Costimulatory Activation Pathways in Transplant Rejection N. Engl. J. Med., June 18, 1998; 338(25): 1813 - 1821. [Full Text] [PDF]
|
|
|
|
 |
|
 G. P. Basadonna, L. Auersvald, C. Q. Khuong, X. X. Zheng, N. Kashio, D. Zekzer, M. Minozzo, H.-Y. Qian, L. Visser, A. Diepstra, et al. Antibody-mediated targeting of CD45 isoforms: A novel immunotherapeutic strategy PNAS, March 31, 1998; 95(7): 3821 - 3826. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
